- Home
- MLGO vs INKT Comparison
MLGO vs INKT Comparison
Compare MLGO & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- INKT
- Stock Information
- Founded
- MLGO 2018
- INKT 2017
- Country
- MLGO China
- INKT United States
- Employees
- MLGO N/A
- INKT N/A
- Industry
- MLGO EDP Services
- INKT Medicinal Chemicals and Botanical Products
- Sector
- MLGO Technology
- INKT Health Care
- Exchange
- MLGO Nasdaq
- INKT Nasdaq
- Market Cap
- MLGO 32.4M
- INKT 31.2M
- IPO Year
- MLGO N/A
- INKT 2021
- Fundamental
- Price
- MLGO $1.38
- INKT $6.98
- Analyst Decision
- MLGO
- INKT Strong Buy
- Analyst Count
- MLGO 0
- INKT 2
- Target Price
- MLGO N/A
- INKT $37.50
- AVG Volume (30 Days)
- MLGO 42.2M
- INKT 5.4K
- Earning Date
- MLGO 06-10-2025
- INKT 05-15-2025
- Dividend Yield
- MLGO N/A
- INKT N/A
- EPS Growth
- MLGO N/A
- INKT N/A
- EPS
- MLGO 0.55
- INKT N/A
- Revenue
- MLGO $74,185,505.00
- INKT N/A
- Revenue This Year
- MLGO N/A
- INKT N/A
- Revenue Next Year
- MLGO N/A
- INKT N/A
- P/E Ratio
- MLGO $2.67
- INKT N/A
- Revenue Growth
- MLGO N/A
- INKT N/A
- 52 Week Low
- MLGO $1.11
- INKT $4.56
- 52 Week High
- MLGO $509.60
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- MLGO 34.39
- INKT 43.93
- Support Level
- MLGO $1.17
- INKT $6.89
- Resistance Level
- MLGO $1.75
- INKT $7.40
- Average True Range (ATR)
- MLGO 0.50
- INKT 0.43
- MACD
- MLGO 0.27
- INKT -0.01
- Stochastic Oscillator
- MLGO 9.21
- INKT 23.91
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.